REVOLAX SUB-Q w/ LIDOCAINE

Where can I buy this product?

REVOLAX SUB-Q w/ Lidocaine is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support.

Product Information

What is REVOLAX SUB-Q w/ Lidocaine?

REVOLAX SUB-Q w/ Lidocaine is a sterile, viscoelastic, injectable gel composed of highly cross-linked hyaluronic acid (HA) of non-animal origin (derived from Streptococcus zooepidemicus fermentation), manufactured by Across, South Korea. It is described as the thickest and most viscous filler within the Revolax product line, featuring a monophasic, polydensified structure.

This robust formulation contains 24mg/mL of cross-linked hyaluronic acid and includes 0.3% lidocaine hydrochloride to enhance patient comfort during deep injections. According to the manufacturer, it undergoes rigorous purification to minimize bacterial endotoxins and residual BDDE. It is specifically designed for deep subcutaneous to supraperiosteal injection for significant facial augmentation and contouring requiring maximal structural support.

Storage: Store according to manufacturer guidelines, typically between 2°C and 25°C (36°F and 77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that REVOLAX products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners in jurisdictions where its use is legally permitted.

How does REVOLAX SUB-Q w/ Lidocaine work?

REVOLAX SUB-Q w/ Lidocaine is engineered as the most structural filler in the Revolax line, possessing the highest viscosity and cohesivity. This allows it to provide maximum lift, projection, and resistance to deformation when injected into deep tissue planes (deep subcutaneous or onto bone).

Its primary function is to provide significant volume and structural definition for facial contouring, mimicking underlying bone structure in areas like the chin, jawline, and cheekbones. The dense, cross-linked HA gel physically shapes and supports the overlying tissues. The manufacturer claims its structure contributes to longevity by resisting enzymatic breakdown.

Treatment results are intended to be immediate and substantial. The manufacturer suggests a duration of effect lasting approximately 12 to 18 months, influenced by individual factors. The integrated lidocaine is essential for managing discomfort during the deep injections required for this product.

Indications for Use

REVOLAX SUB-Q w/ Lidocaine is typically indicated for adults seeking significant facial augmentation and contouring:

• Correction of extremely severe facial wrinkles and folds requiring deep structural support.
• Major facial contouring, including cheekbone, chin, and jawline augmentation requiring maximum projection and definition.
• Restoration of significant age-related volume loss in deep tissue compartments.

Appropriate patient selection and advanced deep injection techniques are crucial where its use is permitted.

Primary Benefits

• Highest viscosity formulation in the Revolax line for maximum lift and structural support.
• Designed for deep subcutaneous/supraperiosteal injection for significant facial contouring.
• Monophasic, polydensified structure for potentially smooth integration (manufacturer claim).
• High purity HA with low endotoxin/residual BDDE levels (manufacturer claim).
• Long-lasting results claimed (12-18 months).
• Contains lidocaine for improved patient comfort during deep injections.

Side Effects and Safety Information

Common side effects expected with deep HA filler injections include temporary, injection-site related reactions:

• Swelling (can be significant initially)
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Palpable Lumps/Bumps (may be more noticeable due to product firmness)

Severe Adverse Events:
Injecting highly viscous fillers deeply carries significant risks. Practitioners must be prepared to manage serious complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to severe tissue necrosis, scarring, or (in rare cases involving facial arteries) blindness or stroke. Knowledge of deep facial anatomy is paramount.
• Severe allergic reactions or hypersensitivity
• Inflammation, infection, or abscess formation (risk may be higher with deep placement)
• Nerve damage or impingement (due to deep injection near critical nerves)
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation.